The IMAGINE Study: An Investigational Therapy to Treat Chronic Active Antibody-Mediated Rejection in Kidney Transplant Recipients
A Single-Arm, Phase 2 Study of Neoadjuvant Carboplatin and Mirvetuximab Soravtansine in Subjects with FRα-Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer